TriSalus Life Sciences (TLSI) Interest & Investment Income (2021 - 2026)
TriSalus Life Sciences posted quarterly Interest & Investment Income of $164000.0 for Q1 2026, up 121.62% year-on-year from $74000.0 in Q1 2025, and down 7.34% on a QoQ basis from $177000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) has 6 years of Interest & Investment Income data on file, last reported at $164000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 121.62% year-over-year to $164000.0; the trailing twelve-month figure through Mar 2026 stood at $645000.0 (up 67.1% YoY), and the FY2025 full-year result was $555000.0, up 37.38% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $164000.0, down from $177000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $314714.0 in Q2 2022 and bottomed at $35000.0 in Q1 2023.
- The 5-year median for Interest & Investment Income is $105000.0 (2022), against an average of $122347.9.
- The widest annual swing landed in 2022, when Interest & Investment Income jumped 11171.99%; it then tumbled 88.56% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $105000.0 in 2022, then surged by 132.38% to $244000.0 in 2023, then plunged by 76.64% to $57000.0 in 2024, then surged by 210.53% to $177000.0 in 2025, then dropped by 7.34% to $164000.0 in 2026.
- The last three Interest & Investment Income figures came in at $164000.0 (Q1 2026), $177000.0 (Q4 2025), and $170000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -25.76 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | TriSalus Life Sciences | 187.09 Mn | 130.54 Mn | 7.67 Mn | 164,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 164,000.00 |
| Dec 31, 2025 | 177,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 57,000.00 |
| Sep 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 97,000.00 |
| Mar 31, 2024 | 92,000.00 |
| Dec 31, 2023 | 244,000.00 |
| Sep 30, 2023 | 116,000.00 |
| Jun 30, 2023 | 36,000.00 |
| Mar 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 49,000.00 |
| Jun 30, 2022 | 314,714.00 |
| Mar 31, 2022 | 57,200.00 |
| Dec 31, 2021 | 7,916.00 |
| Sep 30, 2021 | 18,665.00 |
| Jun 30, 2021 | 2,792.00 |
| Mar 31, 2021 | 34,624.00 |